Case Study

Pharma Company accelerates rare blood disorder launch readiness with KoLab

AI-Powered asynchronous advisory platform helped a pharma team gather physician feedback faster and smarter

5 min read

Hematology · Life Sciences

KoLab

Improved HCP Engagement

AI-Powered Insights

Less administrative complexity

Background

A Rare Disease Team Preparing for Launch

Pharma Co's rare blood disorders team is responsible for hemophilia and related conditions. Like most pharma teams, they relied heavily on traditional advisory boards — in-person gatherings of hematologists, nurses, and allied healthcare providers — to gather strategic insight before and after product launches. These sessions were valuable, but they had limits: constrained by scheduling, travel logistics, and cost — the team had narrow windows to engage their advisors and act on what they heard.

With a significant product launch on the horizon, they required a faster, more flexible approach to continuous HCP engagement. Specifically, they wanted their advisors to be among the first to see both HCP- and patient-facing materials — using the opportunity to gather candid early feedback and surface unmet educational needs in the hemophilia management and treatment space. Specifically, they wanted visibility into actual patient uptake, how physician behaviour would evolve over time and ongoing barriers to patient initiation. The question wasn't whether their advisors had valuable perspectives. It was whether the traditional format could unlock them quickly enough.

The Challenge

Why Traditional Advisory Boards Weren't Enough

Scheduling bottlenecks. Coordinating busy HCP schedules for in-person advisory boards was time-consuming and limited how often the team could gather insights.

High Cost and complexity. Flying in advisors from across the country was expensive, often timed around conferences to justify the effort.

Low participation. In live sessions, physicians had only ~15 minutes to review marketing materials in small groups, with only a handful providing meaningful feedback.

Launch timing pressure. Traditional advisory board timelines didn't align with the pace of a product launch — the team needed feedback fast, not quarterly.

The Solution

An Async Advisory Session Built for Launch Speed

In November, Pharma Co ran their first KeyOps KoLab session — a cross-functional engagement designed to gather HCP feedback on launch marketing materials before the new year. The objective: validate product sheets, patient materials, messaging, and visual aids that had been developed but never tested with physicians. The KeyOps team onboarded HCPs onto the KoLab platform, providing participants a two-week window to annotate materials, answer survey questions, and provide commentary on their own schedule.

Every HCP was engaged in KoLab. The more annotations you have per section, you can see where the interest is or where we needed to make changes directly in KoLab. Seeing people do this at live sessions before — you'd get maybe 15 minutes in small groups to go through a flurry of materials, and maybe two people give valuable feedback. With KoLab, we got valuable insights from all our targeted HCPs.

Senior PM, Rare Blood Disorders

Global Pharmaceutical Company

Results

What the Team Achieved with KoLab

Launch-ready before the holidays. Feedback gathered in November was incorporated into all marketing materials before the Christmas break, so the team entered the new year fully prepared.

Higher engagement quality. The asynchronous format meant every advisor annotated every section — not just the most vocal voices in a room.

Executive-ready reporting. The visual summary report — complete with charts, graphs, and distilled insights — was shared directly with the leadership team.

Organic internal adoption. Word spread: Pharma Co's oncology team signed up independently after learning about the rare blood disorders team's experience.

Expanded KOL engagement strategy. The team now plans to layer KoLab engagements throughout the year alongside traditional advisory boards, increasing total insight-gathering touchpoints.

Looking Ahead

From Pre-Launch to Continuous Insight

With reimbursement decisions pending and a launch on the horizon, Pharma Co's rare blood disorders team plans to use KeyOps to continuously gather insights from physicians as the product moves through different stages of market access. The goal: a living pulse on HCP sentiment and experience — not just a snapshot once or twice a year.

Ready to run your next
advisory session?

See how KoLab helps pharma teams engage HCP advisors asynchronously — with AI-powered insights that are ready before the meeting ends.

Book a Demo Explore KoLab